Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Shifting the Curve in Head and Neck Cancer: More Treatment, Less Treatment, or Better Treatment?. Local targets link to admitted publications; unresolved targets remain external evidence.
10.2139/ssrn.4996826
10.2139/ssrn.4996826 · External reference
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): A randomised, open-label, phase 3 trial
10.1016/s0140-6736(25)01850-1 · 2026 · External reference
Proton beam therapy for oropharyngeal cancer (TORPEdO): A phase 3, randomised controlled trial
10.1016/s0140-6736(26)00314-4 · 2026 · External reference
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: A multicentre, randomised, open-label, non-inferiority phase 3 trial
10.1016/s0140-6736(25)01962-2 · 2026 · External reference
Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer
10.1056/nejmoa2415434 · 2025 · External reference
Primary chemotherapy in resectable oral cavity squamous cell cancer: A randomized controlled trial
10.1200/jco.2003.06.146 · 2003 · External reference
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma
10.1200/jco.2012.43.8820 · 2013 · External reference
Unresolved reference
External reference
Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma
10.1056/nejmoa2211437 · 2023 · External reference
